Category: Disease Prevention & Management

Insulet Corporation, a global leader in tubeless insulin pump technology, has announced a strategic partnership with Calm, the world’s leading mental health platform, to address the significant emotional and psychological challenges faced by the diabetes community. This collaboration marks a milestone in the medical technology sector, representing Calm’s first-ever integrated content partnership with a MedTech…

On July 15, a landmark coalition led by the American College of Obstetricians and Gynecologists (ACOG), the Society for Women’s Health Research (SWHR), and the Women First Research Coalition (WFRC) officially introduced the National Strategy to Close the Women’s Health Gap. This ambitious and comprehensive framework serves as a direct appeal to the United States…

The intersection of clinical expertise and humanistic care remains a focal point for the medical community as the healthcare landscape becomes increasingly digitized and data-driven. Following the most recent Excellence in Clinical Endocrinology Leadership (EXCEL) meeting held at the Endocrine Society’s headquarters in Washington, D.C., medical professionals are re-evaluating the role of empathy and continuous…

The Centers for Medicare & Medicaid Services (CMS) officially released the Calendar Year (CY) 2027 Medicare Physician Fee Schedule (MPFS) proposed rule on July 14, marking the beginning of a critical period for federal healthcare reimbursement policy. This annual regulatory package outlines the payment rates, quality reporting requirements, and policy changes that will govern how…

The medical landscape is currently undergoing a transformative shift as artificial intelligence (AI) transitions from a technological novelty into a fundamental clinical necessity. This evolution was the focal point of a high-profile session at ENDO 2026, the Endocrine Society’s annual meeting, held on Saturday, June 13th. Titled "Artificial Intelligence in Endocrinology: Practical Uses, Lessons Learned,…

The Endocrine Society has officially released its July edition of Endocrine News, an annual tradition dedicated to spotlighting the achievements of early-career members who are redefining the landscape of hormonal research and clinical practice. This year’s issue arrives at a pivotal moment for the field, as the global healthcare community grapples with rising rates of…

On July 15, a powerful coalition of 37 professional medical, patient advocacy, and research organizations, led by the Endocrine Society, the Society for Women’s Health Research (SWHR), the American College of Obstetricians and Gynecologists (ACOG), and the Women First Research Coalition (WFRC), converged in Washington, D.C., to unveil a landmark legislative and scientific framework. Titled…

The Endocrine Society has announced a comprehensive expansion and digital transformation of its communication infrastructure, aimed at streamlining the delivery of critical scientific research and clinical guidelines to its global membership. This strategic overhaul reflects a broader trend within the medical community to move away from traditional print-heavy models toward dynamic, multi-channel digital ecosystems. By…

A comprehensive retrospective cohort study presented at the ENDO 2026 annual meeting has unveiled significant fluctuations in how patients utilize glucagon-like peptide-1 (GLP-1) receptor agonists, suggesting that the clinical reality of these "blockbuster" drugs is far more intermittent than previously characterized. The research, which analyzed insurance claims from more than 60,000 Americans, indicates that while…

Recent clinical findings presented at the ENDO 2026 conference have illuminated a critical intersection between hormonal therapy and metabolic health, revealing that while testosterone treatment offers significant benefits for older men at risk of type 2 diabetes, these advantages are inextricably linked to active engagement in lifestyle modifications. Lead researcher Gary Wittert, MBBch, MD, of…